These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12937004)

  • 1. Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis.
    Krüüner A; Jureen P; Levina K; Ghebremichael S; Hoffner S
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2971-3. PubMed ID: 12937004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
    Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
    Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis.
    Alangaden GJ; Kreiswirth BN; Aouad A; Khetarpal M; Igno FR; Moghazeh SL; Manavathu EK; Lerner SA
    Antimicrob Agents Chemother; 1998 May; 42(5):1295-7. PubMed ID: 9593173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.
    Jugheli L; Bzekalava N; de Rijk P; Fissette K; Portaels F; Rigouts L
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5064-8. PubMed ID: 19752274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-occurrence of amikacin-resistant and -susceptible Mycobacterium tuberculosis isolates in clinical samples from Beijing, China.
    Zhang X; Zhao B; Huang H; Zhu Y; Peng J; Dai G; Jiang G; Liu L; Zhao Y; Jin Q
    J Antimicrob Chemother; 2013 Jul; 68(7):1537-42. PubMed ID: 23539239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.
    Engström A; Perskvist N; Werngren J; Hoffner SE; Juréen P
    J Antimicrob Chemother; 2011 Jun; 66(6):1247-54. PubMed ID: 21427106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of Mycobacterium tuberculosis isolates resistant to kanamycin and amikacin.
    Kumar B; Sharma D; Sharma P; Katoch VM; Venkatesan K; Bisht D
    J Proteomics; 2013 Dec; 94():68-77. PubMed ID: 24036035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China.
    Du Q; Dai G; Long Q; Yu X; Dong L; Huang H; Xie J
    Diagn Microbiol Infect Dis; 2013 Oct; 77(2):138-42. PubMed ID: 23948547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.
    Zaunbrecher MA; Sikes RD; Metchock B; Shinnick TM; Posey JE
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20004-9. PubMed ID: 19906990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin.
    Sugawara I; Zhang J; Li C
    Indian J Exp Biol; 2009 Jun; 47(6):520-2. PubMed ID: 19634718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.
    Brossier F; Pham A; Bernard C; Aubry A; Jarlier V; Veziris N; Sougakoff W;
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets.
    Sharma D; Kumar B; Lata M; Joshi B; Venkatesan K; Shukla S; Bisht D
    PLoS One; 2015; 10(10):e0139414. PubMed ID: 26436944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
    Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
    Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen testing.
    Chakravorty S; Lee JS; Cho EJ; Roh SS; Smith LE; Lee J; Kim CT; Via LE; Cho SN; Barry CE; Alland D
    J Clin Microbiol; 2015 Jan; 53(1):43-51. PubMed ID: 25339395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M. tuberculosis ferritin (Rv3841): Potential involvement in Amikacin (AK) & Kanamycin (KM) resistance.
    Sharma D; Lata M; Faheem M; Khan AU; Joshi B; Venkatesan K; Shukla S; Bisht D
    Biochem Biophys Res Commun; 2016 Sep; 478(2):908-12. PubMed ID: 27521892
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Dijkstra JA; van der Laan T; Akkerman OW; Bolhuis MS; de Lange WCM; Kosterink JGW; van der Werf TS; Alffenaar JWC; van Soolingen D
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain.
    Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):33. PubMed ID: 30008266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.
    Brossier F; Guindo D; Pham A; Reibel F; Sougakoff W; Veziris N; Aubry A
    J Clin Microbiol; 2016 Jun; 54(6):1573-1580. PubMed ID: 27053671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Park J; Shin SY; Kim K; Park K; Shin S; Ihm C
    Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.